We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Continuous Intrathecal Baclofen Infusion for Spasticity of Cerebral Origin

A. Leland Albright, MD; Wendy B. Barron, PT; M. Pat Fasick, OTR/L; Paul Polinko, MSW, LSW; Janine Janosky, PhD
JAMA. 1993;270(20):2475-2477. doi:10.1001/jama.1993.03510200081036.
Text Size: A A A
Published online


Objective.  —To determine if continuous intrathecal baclofen infusion (CIBI) would provide continuous relief of spasticity in patients with spasticity of cerebral origin, especially children with cerebral palsy.

Design.  —Prospective, unblinded trial, before and after CIBI.

Setting.  —Children's Hospital of Pittsburgh (Pa).

Patients.  —Thirty-seven patients, 5 to 27 years of age, with spasticity of cerebral origin.

Intervention.  —Continuous intrathecal baclofen infusion for 3 to 48 months.

Main Outcome Measures.  —Muscle tone, range of motion, upper extremity timed tasks, activities of daily living (ADLs).

Results.  —Six and 12 months after CIBI, muscle tone was significantly decreased in the upper (P=.04) and lower (P=.001) extremities. There was a significant relationship between baclofen dosage and muscle tone in the upper (P=.02) and lower (P=.001) extremities. Hamstring motion, upper extremity function, and ADLs were significantly improved in 25 patients who were capable of self-care.

Conclusion.  —Spasticity of cerebral origin can be effectively treated with CIBI. Because baclofen dosages can be titrated for the desired clinical response, CIBI is particularly useful for patients who need some spasticity to stand and ambulate.(JAMA. 1993;270:2475-2477)


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.